Literature DB >> 21035535

Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation.

Julie M Skinner1, Ivette C Caro-Aguilar, Angela M Payne, Lani Indrawati, Jane Fontenot, Jon H Heinrichs.   

Abstract

Animal models predictive of human disease are generally difficult to establish and reproduce. In the case of the Group A Streptococcus (GAS) bacterium, which is predominantly a human pathogen, virulence assessment in animal models is problematic. We compared a monkey colonization and pharyngitis model of infection in two macaque species to determine the optimal model for vaccine candidate evaluation. Rhesus and cynomolgus macaques were intranasally infected with a streptomycin resistant (Str(r)) GAS strain. Monkeys were monitored for body weight and temperature changes, throat swabs and sera were collected, and clinical observations were noted throughout the study. Both species exhibited oropharyngeal colonization by GAS, with rhesus macaques demonstrating a more sustained colonization through day 28 post-challenge. Veterinary observations revealed no significant differences between GAS-infected rhesus and cynomolgus macaques. Mock-infected monkeys did not exhibit clinical symptoms or GAS colonization throughout the study. ELISA results demonstrated that both rhesus and cynomolgus macaques developed anti-streptolysin-O antibody titers, with cynomolgus generating higher titers. Sera from infected monkeys produced opsonophagocytic killing and bound to the bacterium in an immunofluorescence assay. Both rhesus and cynomolgus macaques can be used for colonization studies with this GAS M3 strain, yet only mild clinical signs of pharyngitis and tonsillitis were observed.
Copyright © 2010. Published by Elsevier India Pvt Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035535     DOI: 10.1016/j.micpath.2010.10.004

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  An emm-type specific qPCR to track bacterial load during experimental human Streptococcus pyogenes pharyngitis.

Authors:  Loraine V Fabri; Kristy I Azzopardi; Joshua Osowicki; Hannah R Frost; Pierre R Smeesters; Andrew C Steer
Journal:  BMC Infect Dis       Date:  2021-05-21       Impact factor: 3.090

2.  Genomic Landscape of Intrahost Variation in Group A Streptococcus: Repeated and Abundant Mutational Inactivation of the fabT Gene Encoding a Regulator of Fatty Acid Synthesis.

Authors:  Jesus M Eraso; Randall J Olsen; Stephen B Beres; Priyanka Kachroo; Adeline R Porter; Waleed Nasser; Paul E Bernard; Frank R DeLeo; James M Musser
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

3.  The contribution of non-human primate models to the development of human vaccines.

Authors:  Tania Rivera-Hernandez; Diane G Carnathan; Peter M Moyle; Istvan Toth; Nicholas P West; Paul R Young; Guido Silvestri; Mark J Walker
Journal:  Discov Med       Date:  2014-12       Impact factor: 2.970

4.  Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.

Authors:  Ivette Caro-Aguilar; Elizabeth Ottinger; Robert W Hepler; Deborah D Nahas; Chengwei Wu; Michael F Good; Michael Batzloff; Joseph G Joyce; Jon H Heinrichs; Julie M Skinner
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

5.  Murine vaginal colonization model for investigating asymptomatic mucosal carriage of Streptococcus pyogenes.

Authors:  Michael E Watson; Hailyn V Nielsen; Scott J Hultgren; Michael G Caparon
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

6.  Galleria mellonella larvae as an infection model for group A streptococcus.

Authors:  Jacelyn M S Loh; Nazneen Adenwalla; Siouxsie Wiles; Thomas Proft
Journal:  Virulence       Date:  2013-05-07       Impact factor: 5.882

Review 7.  Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus.

Authors:  Shu Ki Tsoi; Pierre R Smeesters; Hannah R C Frost; Paul Licciardi; Andrew C Steer
Journal:  J Immunol Res       Date:  2015-05-25       Impact factor: 4.818

8.  Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.

Authors:  Tania Rivera-Hernandez; Manisha Pandey; Anna Henningham; Jason Cole; Biswa Choudhury; Amanda J Cork; Christine M Gillen; Khairunnisa Abdul Ghaffar; Nicholas P West; Guido Silvestri; Michael F Good; Peter M Moyle; Istvan Toth; Victor Nizet; Michael R Batzloff; Mark J Walker
Journal:  mBio       Date:  2016-06-14       Impact factor: 7.867

9.  Contribution of cryptic epitopes in designing a group A streptococcal vaccine.

Authors:  Victoria Ozberk; Manisha Pandey; Michael F Good
Journal:  Hum Vaccin Immunother       Date:  2018-06-14       Impact factor: 3.452

Review 10.  Towards developing a vaccine for rheumatic heart disease.

Authors:  Geethanjali Devadoss Gandhi; Navaneethakrishnan Krishnamoorthy; Ussama M Abdel Motal; Magdi Yacoub
Journal:  Glob Cardiol Sci Pract       Date:  2017-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.